BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20522960)

  • 1. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
    Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
    Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats.
    Srinivasan K; Patole PS; Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):327-33. PubMed ID: 15319810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
    Gad MZ; Ehssan NA; Ghiet MH; Wahman LF
    Pak J Pharm Sci; 2010 Jul; 23(3):305-12. PubMed ID: 20566445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone ameliorates the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice.
    Takada S; Hirabayashi K; Kinugawa S; Yokota T; Matsushima S; Suga T; Kadoguchi T; Fukushima A; Homma T; Mizushima W; Masaki Y; Furihata T; Katsuyama R; Okita K; Tsutsui H
    Eur J Pharmacol; 2014 Oct; 740():690-6. PubMed ID: 24964389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
    Souza-Mello V; Gregório BM; Cardoso-de-Lemos FS; de Carvalho L; Aguila MB; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2010 Jun; 119(6):239-50. PubMed ID: 20415664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
    Hwang JS; Park JW; Nam MS; Cho H; Han IO
    Metabolism; 2015 Mar; 64(3):368-79. PubMed ID: 25516476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
    Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-fat diet-induced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice.
    Townsend KL; Lorenzi MM; Widmaier EP
    Endocrine; 2008 Apr; 33(2):176-88. PubMed ID: 18483882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Obesity and Anti-Diabetic Effect of Neoagarooligosaccharides on High-Fat Diet-Induced Obesity in Mice.
    Hong SJ; Lee JH; Kim EJ; Yang HJ; Park JS; Hong SK
    Mar Drugs; 2017 Mar; 15(4):. PubMed ID: 28333098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21.
    Tian L; Ning H; Shao W; Song Z; Badakhshi Y; Ling W; Yang BB; Brubaker PL; Jin T
    J Nutr; 2020 Aug; 150(8):2101-2111. PubMed ID: 32470979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.
    Al-Barazanji K; McNulty J; Binz J; Generaux C; Benson W; Young A; Chen L
    J Pharmacol Exp Ther; 2015 Jun; 353(3):496-504. PubMed ID: 25770135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic p,p'-dichlorodiphenyldichloroethylene (DDE) exposure on high fat diet-induced alterations in glucose and lipid metabolism in male C57BL/6H mice.
    Howell GE; Mulligan C; Meek E; Chambers JE
    Toxicology; 2015 Feb; 328():112-22. PubMed ID: 25541407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet.
    Wang ZQ; Zuberi AR; Zhang XH; Macgowan J; Qin J; Ye X; Son L; Wu Q; Lian K; Cefalu WT
    Metabolism; 2007 Dec; 56(12):1635-42. PubMed ID: 17998014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid and rosiglitazone combination improves insulin sensitivity by increasing the skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat diet-fed C57BL/6J mice.
    Sundaresan A; Radhiga T; Pugalendi KV
    J Physiol Biochem; 2016 Jun; 72(2):345-52. PubMed ID: 27090933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats.
    Yasuda N; Inoue T; Nagakura T; Yamazaki K; Kira K; Saeki T; Tanaka I
    J Pharmacol Exp Ther; 2004 Aug; 310(2):614-9. PubMed ID: 15039452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.